Hedge funds are doubling down on commodities bets with some notching big gains

Hedge funds are doubling down on commodities bets with some notching big gains


Some pumpjacks operate while others stand idle in the Belridge oil field on November 03, 2021 near McKittrick, California.

Mario Tama | Getty Images

(Click here to subscribe to the Delivering Alpha newsletter.)

Hedge funds have ramped up their commodity bets as prices surged during geopolitical turmoil, and managers with big exposure are reaping sizable profits.

The energy sector saw the most net buying from hedge funds last month compared to other groups of stocks, according to Morgan Stanley prime brokerage data. The combination of the buying and energy’s outperformance resulted in net exposure reaching a two-year high for the hedge fund community, the data said.

Commodities have been a clear winner on Wall Street this year as global demand and the war in Ukraine strained supply. WTI crude oil topped $130 per barrel briefly last week — a 13-year high — during escalated geopolitical tensions. On the back of surging oil, the S&P 500 energy sector has rallied 30% this year, far outpacing the broader market.

Other commodities prices have also shot up amid the disruption. Aluminum recently reached record highs, while wheat futures hit multiyear peaks amid a supply crunch. Nickel prices more than doubled in a matter of hours on March 8, climbing above $100,000 a metric ton amid a massive short squeeze. Heating Oil futures have surged more than 30% this year.

Contrarian value-focused hedge fund Equinox Partners, which is concentrated on precious metals miners and exploration & production companies, has returned over 14% year to date, according to a person familiar with the firm’s returns.

“They are good inflation hedges and good geopolitical hedges,” said Sean Fieler at chief investment officer at Equinox Partners. “There is a longer term story. Metals are the energy of the future, and I think it’s going to take the market some time to get its head around that.”

Meanwhile, Soroban Capital made at least several hundred million dollars from its commodity bets since February, the Wall Street Journal reported. Soroban didn’t respond to CNBC’s request for comment.

Other notable investors are also doubling down on the energy sector.

Warren Buffett’s Berkshire Hathaway continued to scoop up shares of Occidental Petroleum this week, bringing its total stake in the oil giant to over $7 billion after the recent buying spree.

Billionaire investor Leon Cooperman said earlier this week energy stocks are cheap relative to commodity prices. He said his two favorites are Canadian companies Tourmaline Oil and Paramount Resources.



Source

Warren Buffett’s Berkshire Hathaway reveals new position in Alphabet
Finance

Warren Buffett’s Berkshire Hathaway reveals new position in Alphabet

Warren Buffett speaks during the Berkshire Hathaway Annual Shareholders Meeting in Omaha, Nebraska on May 3, 2025. CNBC Warren Buffett’s Berkshire Hathaway revealed a new position in Alphabet, making the Google parent the conglomerate’s 10th largest equity holding at the end of September, according to a regulatory filing. Berkshire disclosed a $4.3 billion stake in […]

Read More
Stocks making the biggest moves midday: Whirlpool, Topgolf Callaway, Nvidia, Stubhub & more
Finance

Stocks making the biggest moves midday: Whirlpool, Topgolf Callaway, Nvidia, Stubhub & more

Check out the companies making the biggest moves midday: Scholar Rock — The Cambridge, Massachusetts-based biotech jumped 23% after saying it ” completed constructive and collaborative in-person Type A meeting ” with the FDA on Wednesday for a biologics license application for apitegromab, a spinal muscular atrophy treatment. Officials from Novo Nordisk’s Catalent Indiana joined […]

Read More
Stocks making the biggest premarket moves: Warner Bros. Discovery, Cidara Therapeutics, Avadel Pharmaceuticals and more
Finance

Stocks making the biggest premarket moves: Warner Bros. Discovery, Cidara Therapeutics, Avadel Pharmaceuticals and more

Check out the companies making headlines before the bell. Cidara Therapeutics — Shares of Cidara surged 103% after Merck agreed to buy the company for close to $9.2 billion in cash. Merck fell 1%. Avadel Pharmaceuticals — Danish drugmaker Lundbeck offered to acquire the pharmaceutical company for as much as $23 per share, topping biotech […]

Read More